NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
Misunderstood ATOs Are Costing Agencies Time, Money
Institutional confusion about ATOs is creating avoidable delays, while modern DevSecOps approaches offer a faster path to software delivery.
9m watch -
VA Pilot Shows Value of AI-Powered VR Training
A VA proof-of-concept pilot is demonstrating how AI-enabled virtual reality training boosts knowledge scores and lowers training costs.
3m read -
AI Powers Smithsonian’s Digital Transformation for America250
The Smithsonian is applying AI to research, digital collections and visitor experiences as it prepares for America250.
12m listen -
VA Deploys EHR System to Four More Medical Centers
More than 107,000 veterans and 7,200 clinicians are impacted by VA's latest electronic health record deployment across Ohio and Kentucky.
2m read
